NVS - 5 Potential Biotech M&A Targets To Watch In 2019
Merger Monday is alive and well in the healthcare sector with two big acquisitions thus far in 2019 with Bristol-Myers agreeing to buy Celgene Corp. in a deal valued at $74 billion and Eli Lilly & Company agreeing to acquire Loxo Oncology Inc. for roughly $8 billion. Only time will tell if these two acquisitions open the floodgates for a big year of M&A in the healthcare sector. In this article, I will discuss 5 companies that I own and believe are possible takeout targets for 2019.
The Medicines Company (MDCO)
The Medicines